Literature DB >> 10200537

Non-cell autonomous induction of apoptosis and loss of posterior structures by activation domain-specific interactions of Oct-1 in the Xenopus embryo.

G J Veenstra1, J Peterson-Maduro, M T Mathu, P C van der Vliet, O H Destrée.   

Abstract

Oct-1, a member of the POU family of transcription factors, is expressed at relatively high levels in ectodermal and mesodermal cell lineages during early Xenopus embryogenesis (Veenstra et al, 1995). Here we show that overexpression of Oct-1 induces programmed cell death concomitant with the loss of the posterior part of the body axis. Truncated Oct-1 variants, missing either the C-terminal or N-terminal trans-activation domain, exhibit a different capacity to cause such developmental defects. Oct-1-induced cell death is rescued in unilaterally injected embryos by non-injected cells, indicative of the non-cell autonomous character of the developmental effects of Oct-1. This was confirmed by marker gene analysis, which showed a significant decrease in brachyury expression, suggesting that Oct-1 interferes with an FGF-type signalling pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10200537     DOI: 10.1038/sj.cdd.4400416

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  10 in total

1.  PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development.

Authors:  Zhigang Jin; Lindsay Wallace; Scott Q Harper; Jing Yang
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

2.  POU-V factors antagonize maternal VegT activity and beta-Catenin signaling in Xenopus embryos.

Authors:  Ying Cao; Doreen Siegel; Cornelia Donow; Sigrun Knöchel; Li Yuan; Walter Knöchel
Journal:  EMBO J       Date:  2007-05-31       Impact factor: 11.598

3.  Translation of maternal TATA-binding protein mRNA potentiates basal but not activated transcription in Xenopus embryos at the midblastula transition.

Authors:  G J Veenstra; O H Destrée; A P Wolffe
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

4.  POU homeodomain protein OCT1 modulates islet 1 expression during cardiac differentiation of P19CL6 cells.

Authors:  Yinan Liu; Yanming Li; Tao Li; Huafei Lu; Zhuqing Jia; Weiping Wang; Ping Chen; Kangtao Ma; Chunyan Zhou
Journal:  Cell Mol Life Sci       Date:  2010-10-21       Impact factor: 9.261

5.  Growth and apoptosis during larval forelimb development and adult forelimb regeneration in the newt ( Notophthalmus viridescens).

Authors:  Tatjana Vlaskalin; Christine J Wong; Catherine Tsilfidis
Journal:  Dev Genes Evol       Date:  2004-08-21       Impact factor: 0.900

Review 6.  Octamer-binding transcription factors: genomics and functions.

Authors:  Feng-Qi Zhao
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

7.  Different N-terminal isoforms of Oct-1 control expression of distinct sets of genes and their high levels in Namalwa Burkitt's lymphoma cells affect a wide range of cellular processes.

Authors:  Elizaveta V Pankratova; Alexander G Stepchenko; Tatiana Portseva; Vladic A Mogila; Sofia G Georgieva
Journal:  Nucleic Acids Res       Date:  2016-07-12       Impact factor: 16.971

8.  mNanog possesses dorsal mesoderm-inducing ability by modulating both BMP and Activin/nodal signaling in Xenopus ectodermal cells.

Authors:  Aya Miyazaki; Kentaro Ishii; Satoshi Yamashita; Susumu Nejigane; Shinya Matsukawa; Yuzuru Ito; Yasuko Onuma; Makoto Asashima; Tatsuo Michiue
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

9.  Activation of a T-box-Otx2-Gsc gene network independent of TBP and TBP-related factors.

Authors:  Emese Gazdag; Ulrike G Jacobi; Ila van Kruijsbergen; Daniel L Weeks; Gert Jan C Veenstra
Journal:  Development       Date:  2016-03-07       Impact factor: 6.868

10.  The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells.

Authors:  Elizaveta V Pankratova; Alexander G Stepchenko; Irina D Krylova; Tatiana N Portseva; Sofia G Georgieva
Journal:  Oncotarget       Date:  2018-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.